Atlas Trials

An Open-label Extension Trial to Investigate Possible Drug-drug Interactions Between Stiripentol or Valproate and Cannabidiol in Patients With Epilepsy

Clinical trial NCT02607904 · COMPLETED

Trial details

NCT number
NCT02607904
Sponsor
Jazz Pharmaceuticals
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Epilepsy
Start date
2016-12-15
Primary completion
2019-05-27
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.